Literature DB >> 17493036

Widespread demyelination in the cerebellar cortex in multiple sclerosis.

Alexandra Kutzelnigg1, Jens C Faber-Rod, Jan Bauer, Claudia F Lucchinetti, Per S Sorensen, Henning Laursen, Christine Stadelmann, Wolfgang Brück, Helmut Rauschka, Manfred Schmidbauer, Hans Lassmann.   

Abstract

Neocortical demyelination in the forebrain has recently been identified as an important pathological feature of multiple sclerosis (MS). Here we describe that the cerebellar cortex is a major predilection site for demyelination, in particular in patients with primary and secondary progressive MS. In these patients, on average, 38.7% of cerebellar cortical area is affected, reaching in extreme examples up to 92%. Cerebellar cortical demyelination occurs mainly in a band-like manner, affecting multiple folia. The lesions are characterized by primary demyelination with relative axonal and neuronal preservation, although some axonal spheroids and a moderate reduction of Purkinje cells are present. Although cortical demyelination sometimes occurs together with demyelination in the adjacent white matter (leukocortical lesions), in most instances, the cortex was affected independently from white matter lesions. We found no correlation between demyelination in the cortex and the white matter, and in some cases, extensive cortical demyelination was present in the near absence of white matter lesions. Our data identify cortical demyelination as a potential substrate of cerebellar dysfunction in MS.

Entities:  

Mesh:

Year:  2007        PMID: 17493036     DOI: 10.1111/j.1750-3639.2006.00041.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  92 in total

1.  Impairments in Walking Ability, Dexterity, and Cognitive Function in Multiple Sclerosis Are Associated with Different Regional Cerebellar Gray Matter Loss.

Authors:  Matthias Grothe; Martin Lotze; Sönke Langner; Alexander Dressel
Journal:  Cerebellum       Date:  2017-12       Impact factor: 3.847

2.  In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI.

Authors:  Caterina Mainero; T Benner; A Radding; A van der Kouwe; R Jensen; B R Rosen; R P Kinkel
Journal:  Neurology       Date:  2009-07-29       Impact factor: 9.910

Review 3.  Multiple sclerosis.

Authors:  Massimo Filippi; Amit Bar-Or; Fredrik Piehl; Paolo Preziosa; Alessandra Solari; Sandra Vukusic; Maria A Rocca
Journal:  Nat Rev Dis Primers       Date:  2018-11-08       Impact factor: 52.329

4.  Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis.

Authors:  P Sati; D M Thomasson; N Li; D L Pham; N M Biassou; D S Reich; J A Butman
Journal:  Mult Scler       Date:  2014-03-17       Impact factor: 6.312

5.  Evidence of diffuse cerebellar neuroinflammation in multiple sclerosis by 11C-PBR28 MR-PET.

Authors:  Valeria T Barletta; Elena Herranz; Costantina A Treaba; Russell Ouellette; Ambica Mehndiratta; Marco L Loggia; Eric C Klawiter; Carolina Ionete; Sloane A Jacob; Caterina Mainero
Journal:  Mult Scler       Date:  2019-04-11       Impact factor: 6.312

Review 6.  Grey matter damage in multiple sclerosis: a pathology perspective.

Authors:  Roel Klaver; Helga E De Vries; Geert J Schenk; Jeroen J G Geurts
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

Review 7.  Grey matter lesions in MS: from histology to clinical implications.

Authors:  Massimiliano Calabrese; Alice Favaretto; Valeria Martini; Paolo Gallo
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

Review 8.  The pathological spectrum of CNS inflammatory demyelinating diseases.

Authors:  Wei Hu; Claudia F Lucchinetti
Journal:  Semin Immunopathol       Date:  2009-09-25       Impact factor: 9.623

9.  Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.

Authors:  Thomas Skripuletz; Maren Lindner; Alexandra Kotsiari; Niklas Garde; Jantje Fokuhl; Franziska Linsmeier; Corinna Trebst; Martin Stangel
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

Review 10.  New concepts on progressive multiple sclerosis.

Authors:  Hans Lassmann
Journal:  Curr Neurol Neurosci Rep       Date:  2007-05       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.